We hypothesize that the abrogation of CCK2R signaling in tumor cells will promote the normalization of the tumor stroma, decrease tumor fibrosis, and improve tumor vascularity which, together, will positively affect nanoparticle access and perfusion. This evidence concerns the gene CCKBR and neoplasm.